Humana Inc. $HUM Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH reduced its stake in Humana by 11.7% in Q4, selling 9,562 shares and retaining 72,042 shares worth about $18.56 million (≈0.06% of the company).
• Humana beat Q4 estimates with EPS of ($3.96) vs. ($4.01) expected and revenue of $32.64 billion (up 11.3% YoY), and set FY2026 guidance of 9.00 EPS (analysts forecast ~9.05).
• The company declared a quarterly dividend of $0.885 per share (annualized $3.54, yield ~1.6%, payable July 31), while Wall Street sentiment is mixed with a MarketBeat consensus Hold and a $222.09 price target amid recent downgrades.

Universal Beteiligungs und Servicegesellschaft mbH lessened its position in Humana Inc. (NYSE:HUM - Free Report) by 11.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 72,042 shares of the insurance provider's stock after selling 9,562 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.06% of Humana worth $18,560,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in HUM. CoreCap Advisors LLC lifted its stake in shares of Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider's stock worth $27,000 after acquiring an additional 37 shares during the period. Rosenberg Matthew Hamilton increased its holdings in shares of Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider's stock valued at $30,000 after purchasing an additional 68 shares in the last quarter. Mather Group LLC. purchased a new position in shares of Humana in the 3rd quarter valued at about $34,000. Private Wealth Management Group LLC increased its holdings in shares of Humana by 47.5% in the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider's stock valued at $39,000 after purchasing an additional 48 shares in the last quarter. Finally, Larson Financial Group LLC increased its holdings in shares of Humana by 114.1% in the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider's stock valued at $40,000 after purchasing an additional 81 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Stock Performance

Shares of HUM opened at $215.26 on Friday. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.70. The stock has a market cap of $25.84 billion, a P/E ratio of 21.92, a PEG ratio of 2.30 and a beta of 0.44. The company has a 50-day moving average of $184.64 and a two-hundred day moving average of $229.11. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $315.35.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($4.01) by $0.05. The company had revenue of $32.64 billion during the quarter, compared to analysts' expectations of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. The firm's quarterly revenue was up 11.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($2.16) earnings per share. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, research analysts predict that Humana Inc. will post 9.05 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.6%. Humana's payout ratio is presently 36.05%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Truist Financial increased their price target on shares of Humana from $200.00 to $220.00 and gave the company a "hold" rating in a report on Monday, April 13th. Weiss Ratings reiterated a "sell (d+)" rating on shares of Humana in a report on Tuesday. The Goldman Sachs Group cut their price target on shares of Humana from $215.00 to $158.00 and set a "sell" rating for the company in a report on Friday, February 13th. UBS Group reiterated a "neutral" rating on shares of Humana in a report on Wednesday, February 25th. Finally, Zacks Research downgraded shares of Humana from a "hold" rating to a "strong sell" rating in a report on Tuesday, April 14th. Seven research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have given a Sell rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $222.09.

Insider Transactions at Humana

In other Humana news, insider Sanjay K. Shetty bought 810 shares of the business's stock in a transaction on Monday, February 23rd. The stock was bought at an average price of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the transaction, the insider owned 11,657 shares in the company, valued at approximately $2,158,992.97. The trade was a 7.47% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.20% of the company's stock.

Humana Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.